|
Half-Dose of novel OAC Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 3: 1
Top Sponsors
- Texas Cardiac Arrhythmia Research Foundation1
Indications
- Atrial Fibrillation (AF)1
- Heart Disease1
Austin, Texas1 trial
Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion
Texas Cardiac Arrhythmia Institute, St. David's Medical Center
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.